Syngulon

Rue Du Bois Saint Jean 15/1

4102 Seraing

BE

Syngulon

Foundation date

07/03/2013

Sector

#Biotechnology - other

Subsector

Syngulon is developing original genetic technologies to improve the efficiency of microorganisms.Syngulon has introduced a new genetic technology (US Patent 9,333,227, issued on May 10, 2016) for the use of bacteriocin/immunity in any bacteria, yeast or algae for controlled growth of microorganisms.This issued patent is part of a new worldwide patent portfolio developed by Syngulon and available for licensing in all fields of use on a non-exclusive basis.  

Upcoming events

Latest news

  • Imec-onderzoekers leggen basis voor in vivo detectie van traag groeiende hersentumoren, met dank aan hyperspectrale camera

    Friday February 3rd 2023

  • Weber joins Vivactis Group to reinforce its Market Access capabilities

    Thursday February 2nd 2023

  • Mithra CDMO announces collaboration with VaRi Bioscience for the development of a long-acting product in women’s health

    Thursday February 2nd 2023